This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

Douglas Evan Godshall net worth and biography

Douglas Godshall Biography and Net Worth

CEO of Shockwave Medical

Doug joined Shockwave as Chief Executive Officer in May 2017 to lead the company into US commercialization and international expansion. This followed his most recent tenure as the CEO and a Director of HeartWare, a leader in the LVAD market. He managed the organization from a pre-commercial phase to over $250M in sales until it was acquired by Medtronic in August of 2016 for $1.1B.

Prior to HeartWare, Doug held other executive and leadership positions at Boston Scientific, including President of the Vascular Surgery Division, member of Boston Sci’s Operating Committee and Vice President of Business Development where he was responsible for more than 70 transactions, many in the arena of coronary and peripheral interventions.

Doug earned an MBA from Northeastern University and a BA in Economics from Lafayette College.

What is Douglas Evan Godshall's net worth?: The estimated net worth of Douglas Evan Godshall is at least $54.48 million as of February 15th, 2024. Mr. Godshall owns 162,762 shares of Shockwave Medical stock worth more than $54,484,580 as of November 23rd. This net worth estimate does not reflect any other assets that Mr. Godshall may own. Additionally, Mr. Godshall receives an annual salary of $1,570,000.00 as CEO at Shockwave Medical. Learn More about Douglas Evan Godshall's net worth.
How old is Douglas Evan Godshall?: Mr. Godshall is currently 59 years old. There are 4 older executives and no younger executives at Shockwave Medical. Learn More on Douglas Evan Godshall's age.
What is Douglas Evan Godshall's salary?: As the CEO of Shockwave Medical, Inc., Mr. Godshall earns $1,570,000.00 per year. Learn More on Douglas Evan Godshall's salary.
How do I contact Douglas Evan Godshall?: The corporate mailing address for Mr. Godshall and other Shockwave Medical executives is 5403 Betsy Ross Drive, Santa Clara CA, 95054. Shockwave Medical can also be reached via phone at (877) 775-4846 and via email at [email protected]. Learn More on Douglas Evan Godshall's contact information.
Has Douglas Evan Godshall been buying or selling shares of Shockwave Medical?: Douglas Evan Godshall has not been actively trading shares of Shockwave Medical during the last quarter. Most recently, Douglas Evan Godshall sold 10,000 shares of the business's stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $231.56, for a transaction totalling $2,315,600.00. Following the completion of the sale, the chief executive officer now directly owns 162,762 shares of the company's stock, valued at $37,689,168.72. Learn More on Douglas Evan Godshall's trading history.
Who are Shockwave Medical's active insiders?: Shockwave Medical's insider roster includes Colin Cahill (Director), Laura Francis (Director), Douglas Godshall (CEO), Antoine Papiernik (Director), Trinh Phung (VP), Dan Puckett (CFO), Maria Sainz (Director), Frank Watkins (Director), and Isaac Zacharias (Insider). Learn More on Shockwave Medical's active insiders.
Are insiders buying or selling shares of Shockwave Medical?: In the last year, insiders at the sold shares 21 times. They sold a total of 129,216 shares worth more than $30,809,995.81. The most recent insider tranaction occured on March, 26th when Director Laura Francis sold 1,500 shares worth more than $450,000.00. Insiders at Shockwave Medical own 3.4% of the company. Learn More about insider trades at Shockwave Medical.
Information on this page was last updated on 3/26/2024.

Douglas Evan Godshall Insider Trading History at Shockwave Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/15/2024	Sell	10,000	$231.56	$2,315,600.00	162,762
1/16/2024	Sell	10,000	$217.59	$2,175,900.00	141,057
1/5/2024	Sell	10,000	$200.05	$2,000,500.00	141,057
12/15/2023	Sell	5,000	$187.80	$939,000.00	141,057
11/15/2023	Sell	5,000	$174.08	$870,400.00	136,057
10/16/2023	Sell	10,000	$200.78	$2,007,800.00	141,649
9/15/2023	Sell	10,000	$212.86	$2,128,600.00	141,649
8/24/2023	Sell	10,000	$214.62	$2,146,200.00	141,649
2/21/2023	Sell	30,000	$187.84	$5,635,200.00	114,741
11/14/2022	Sell	30,000	$240.81	$7,224,300.00	82,926
8/11/2022	Sell	30,000	$280.60	$8,418,000.00	112,926
6/6/2022	Sell	7,400	$177.32	$1,312,168.00	142,926
5/27/2022	Sell	2,600	$175.06	$455,156.00	142,926
5/13/2022	Sell	5,000	$150.00	$750,000.00	142,926
5/11/2022	Sell	15,000	$140.87	$2,113,050.00	142,926
11/18/2021	Sell	45,000	$207.28	$9,327,600.00
8/18/2021	Sell	45,000	$188.08	$8,463,600.00	181,856
5/18/2021	Sell	45,000	$159.36	$7,171,200.00	181,856
2/18/2021	Sell	45,000	$121.96	$5,488,200.00	193,359
11/17/2020	Sell	132,145	$94.98	$12,551,132.10	230,083
8/27/2020	Sell	849	$60.00	$50,940.00	99,208
8/24/2020	Sell	9,359	$60.00	$561,540.00	107,718
8/21/2020	Sell	16,750	$60.02	$1,005,335.00	125,635
8/4/2020	Sell	19,357	$50.01	$968,043.57	109,002
2/18/2020	Sell	30,000	$43.23	$1,296,900.00	46,000
11/21/2019	Sell	30,000	$37.42	$1,122,600.00	46,000

Douglas Evan Godshall Buying and Selling Activity at Shockwave Medical

Shockwave Medical Company Overview

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Today's Range

Now: $334.75

$334.75

50 Day Range

MA: $332.85

$328.87

$334.83

2 Week Range

Now: $334.75

$157.00

$334.90

Volume

N/A

Average Volume

968,088 shs

Market Capitalization

$12.57 billion

P/E Ratio

78.21

Dividend Yield

N/A

Beta

0.88

Missed Nvidia? Watch this ASAP

From Brownstone Research | Ad

Click here and I’ll tell you everything you need to know.

Douglas Godshall Biography and Net Worth

What is Douglas Evan Godshall's net worth?

How old is Douglas Evan Godshall?

What is Douglas Evan Godshall's salary?

How do I contact Douglas Evan Godshall?

Has Douglas Evan Godshall been buying or selling shares of Shockwave Medical?

Who are Shockwave Medical's active insiders?

Are insiders buying or selling shares of Shockwave Medical?